CORD Webinar 2: When Innovation Rewrites the Pathway

No event found!

Date

Oct 16 2026

Time

12:00 - 13:15

CORD Webinar 2: When Innovation Rewrites the Pathway

From Canadian Experience to Phase 2 Readiness

How can Phase 2 RDDS help Canada anticipate the pathway consequences of new rare and precision therapies – so that screening, diagnosis, eligibility, expertise, delivery, patient choice, monitoring and learning do not have to be rebuilt after each access decision?

Speakers:

  • Kim Steele, Cystic Fibrosis Canada
  • Susi Vander Wyk, Cure SMA Canada
  • Audrey Belouin, Canadian Association of Pompe (TBC)
Register Here

Related Events